Phaos Technology Holdings (Cayman) (POAS) Long-Term Deferred Tax (2024 - 2025)
Phaos Technology Holdings (Cayman) (POAS) posted Long-Term Deferred Tax of $500038.0 for Q4 2025, down 93.38% on a QoQ basis from $7.6 million in Q2 2025.
Phaos Technology Holdings (Cayman) (POAS) Long-Term Deferred Tax (2024 - 2025) Analysis & Trends
Phaos Technology Holdings (Cayman)'s Long-Term Deferred Tax history runs 2 years deep, the most recent figure standing at $500038.0 for Q4 2025.
- Quarterly Long-Term Deferred Tax changed N/A year-over-year to $500038.0 in Q4 2025, while the trailing twelve-month figure through Oct 2025 was $500038.0 (changed N/A YoY) and the FY2025 annual result came in at $497302.0, down 89.75% from the prior year.
- Long-Term Deferred Tax was $500038.0 for Q4 2025 at Phaos Technology Holdings (Cayman), down from $7.6 million in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $7.6 million in Q2 2025 and bottomed at $500038.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.55 Bn | 176.26 Bn | 6.27 Bn |
| 2 | Stryker | 128.64 Bn | 125.76 Bn | 3.81 Bn |
| 3 | Medtronic | 108.92 Bn | 99.70 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.50 Bn | 67.05 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.84 Bn | 44.17 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.25 Bn | 25.96 Bn | 1.98 Bn |
| 7 | Dexcom | 28.23 Bn | 27.11 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.30 Bn | 2.07 Bn |
| 10 | Phaos Technology Holdings (Cayman) | 6.44 Mn | 6.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | 500,038.00 |
| Apr 30, 2025 | 7.55 Mn |
| Apr 30, 2024 | 4.85 Mn |